These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6859985)

  • 1. Lack of correction between activated clotting time and plasma heparin during cardiopulmonary bypass.
    Pi KD
    Ann Surg; 1983 Jul; 198(1):115. PubMed ID: 6859985
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations.
    Despotis GJ; Summerfield AL; Joist JH; Goodnough LT; Santoro SA; Spitznagel E; Cox JL; Lappas DG
    J Thorac Cardiovasc Surg; 1994 Dec; 108(6):1076-82. PubMed ID: 7983877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous use of argatroban and heparin during cardiopulmonary bypass.
    Okamura T; Shin'oka T; Ishibashi N; Ishii H; Kurosawa H
    Asian Cardiovasc Thorac Ann; 2010 Feb; 18(1):22-6. PubMed ID: 20124292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin concentrations in neonates during cardiopulmonary bypass.
    Davidson SJ; Tillyer ML; Keogh J; Hall J; Kelleher AA
    J Thromb Haemost; 2012 Apr; 10(4):730-2. PubMed ID: 22329742
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro and in vivo effects of hemodilution on kaolin-based activated clotting time predicted heparin requirement using a heparin dose-response technique.
    Ichikawa J; Hagihira S; Mori T; Kodaka M; Nishiyama K; Ozaki M; Komori M
    J Anesth; 2016 Dec; 30(6):923-928. PubMed ID: 27502398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
    Guzzetta NA; Monitz HG; Fernandez JD; Fazlollah TM; Knezevic A; Miller BE
    Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extreme Plasma Dilution Decreases Heparin and Protamine Cardiopulmonary Bypass Requirements: A Case Report on a Jehovah's Witness Patient.
    Chang E; Gatling JW; Bode S; Herrmann PC; Bull BS; Applegate RL
    A A Case Rep; 2017 Jun; 8(11):291-293. PubMed ID: 28328588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effect of hemodilution on activated clotting time and high-dose thrombin time during cardiopulmonary bypass.
    Huyzen RJ; van Oeveren W; Wei F; Stellingwerf P; Boonstra PW; Gu YJ
    Ann Thorac Surg; 1996 Aug; 62(2):533-7. PubMed ID: 8694618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin monitoring during cardiopulmonary bypass surgery using the one-step point-of-care whole blood anti-factor-Xa clotting assay heptest-POC-Hi.
    Hellstern P; Bach J; Simon M; Saggau W
    J Extra Corpor Technol; 2007 Jun; 39(2):81-6. PubMed ID: 17672188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass.
    Dietrich W; Spannagl M; Schramm W; Vogt W; Barankay A; Richter JA
    J Thorac Cardiovasc Surg; 1991 Oct; 102(4):505-14. PubMed ID: 1833592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary on: The relationship between heparin level and activated clotting time in the adult cardiac surgery population.
    Fitzgerald D
    Perfusion; 2009 Mar; 24(2):97. PubMed ID: 19654151
    [No Abstract]   [Full Text] [Related]  

  • 14. Does hemodilution by the crystalloid priming solution derange the efficacy of anticoagulation during cardiopulmonary bypass?
    Srivastava AR; Banerjee A; Misra BB; Minhas H; Virmani S
    J Card Surg; 2008; 23(3):239-45. PubMed ID: 18435639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass.
    Culliford AT; Gitel SN; Starr N; Thomas ST; Baumann FG; Wessler S; Spencer FC
    Ann Surg; 1981 Jan; 193(1):105-11. PubMed ID: 6970015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass surgery.
    Babka R; Colby C; El-Etr A; Pifarré R
    J Thorac Cardiovasc Surg; 1977 May; 73(5):780-2. PubMed ID: 850438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RETRACTED: Does the preparation of heparin influence anticoagulation during cardiopulmonary bypass?
    Boldt J; Zickmann B; Ballesteros M; Scholz D; Dapper F; Hempelmann G
    J Cardiothorac Vasc Anesth; 1991 Oct; 5(5):449-453. PubMed ID: 1932649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for monitoring heparin by the activated clotting time when aprotinin is used during cardiopulmonary bypass.
    Hunt BJ; Segal HC; Yacoub M
    J Thorac Cardiovasc Surg; 1992 Jul; 104(1):211-2. PubMed ID: 1377315
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.